Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
2015 ◽
Vol 372
(2)
◽
pp. 134-141
◽
Keyword(s):
2019 ◽
Vol 17
(1)
◽
pp. 47-56
◽
Keyword(s):
Keyword(s):
Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours
2009 ◽
Vol 20
(4)
◽
pp. 373-375
2014 ◽
Vol 21
(11)
◽
pp. 3490-3496
◽
2016 ◽
Keyword(s):
2016 ◽
Vol 34
(6)
◽
pp. 639-640
◽
Keyword(s):
Keyword(s):
Poor survival outcomes in HER2 positive breast cancer patients with low grade, node negative tumours
2008 ◽
Vol 6
(9)
◽
pp. 105-106